Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
The average life expectancy of people diagnosed with dementia ranges from nine years at age 60 to 4.5 years at age 85 for ...
Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...
Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
Researchers found that combining cardiovascular disease drug classes, particularly antihypertensives, can reduce risk of dementia.
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
These concerns include difficulty with medication management ... the ED could help a dementia patient return to an optimal source of longitudinal care while educating them on reasons to return ...